Sökning: "Acute myeloid leukaemia"
Visar resultat 11 - 15 av 20 avhandlingar innehållade orden Acute myeloid leukaemia.
11. Botad - till vilket pris? : en studie över livskvalitet och kostnad vid konventionell behandling av akut myeloisk leukemi = [Cured - at what price?] : [a study on quality of life and costs in conventional treatment of acute myeloid leukaemia]
Sammanfattning : .... LÄS MER
12. Leukaemic relapse after allogeneic haematopoietic stem cell transplantation and the use of the graft-versus-leukaemia effect
Sammanfattning : Survival after allogeneic haematopoietic stem cell transplantation (HSCT) has improved over the last decades due to improvements in immunosuppressive regimens and supportive care. Today the major risk of treatment failure is recurrent leukaemia, a risk which has stayed relatively constant over the years. LÄS MER
13. Indicators of apoptosis and proliferation in haematological malignancies : with special reference to drug resistance and prognosis
Sammanfattning : Successful treatment of acute myeloid leukaemia (AML) and high-grade non-Hodgkin's lymphoma (HG- NHL) is hampered by development of drug resistance. A better understanding of mechanisms responsible for drug resistance and the identification of factors that predict response to therapy is essential to improve treatment. LÄS MER
14. DNA-dependent protein kinase in normal and malignant cells : with special reference to anti-tumour agent sensitivity
Sammanfattning : The DNA-dependent protein kinase (DNA-PK) is a DNA double strand break (DSB) repair enzyme, essential for the cellular response to DNA damaging agents. DNA-PK is also of importance for lymphoid development, since it includes two processes, V(D)J recombination and lg switch recombination, during which DSBs are naturally occurring events. LÄS MER
15. Risk factors for haematological malignancies : immune-mediated diseases, body mass index and magnetic fields
Sammanfattning : Haematological malignancies constitute approximately 7% of all cancer cases in Sweden, and leukaemia is in fact the most common malignancy among children. The few established risk factors, such as ionising radiation and immunodeficiency, only explain a small number of the cases. LÄS MER